Journal Watch 23/10/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
High-dose mazdutide may offer bariatric surgery-equivalent weight lossInnovent Biologics has announced that the outcomes of high-dose cohorts in a phase 1 clinical trial of mazdutide (IBI362) - a...
Benefits of GLP-1 go far beyond diabetesBeyond conventional metabolism, drugs based on GLP-1 can also reduce plaque formation in arteries and control inflammation in several...
SURMOUNT-5: Zepbound superior to Wegovy in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%4 days ago